Suppr超能文献

研讨会总结:“吸气,呼气,如此简单:关于开发吸入药物你需要了解的内容”

Symposium Summary: "Breathe In, Breathe Out, Its Easy: What You Need to Know About Developing Inhaled Drugs".

作者信息

Tepper Jeffrey S, Kuehl Philip J, Cracknell Stuart, Nikula Kristen J, Pei Luqi, Blanchard James D

机构信息

Tepper Nonclinical Consulting, San Carlos, CA, USA

Lovelace Respiratory Research Institute, Albuquerque, NM, USA.

出版信息

Int J Toxicol. 2016 Jul;35(4):376-92. doi: 10.1177/1091581815624080. Epub 2016 Feb 7.

Abstract

Developing inhaled drugs requires knowledge of lung anatomy, cell biology, respiratory physiology, particle physics, and some plumbing. Although dose makes the poison, in the context of an inhaled drug, the "dose" is not easily defined. This lack of clarity around dose poses issues and challenges in the design of inhalation toxicology programs. To better understand dose, the influence of ventilation is discussed as are the perturbations in pulmonary function observed with inhalation exposure that can affect dose. Methods for determining inhaled drug deposition to arrive at an estimate of lung dose are examined. Equally important to understanding dose are the techniques used to deliver aerosols to animals. With a better understanding of dose and inhalation exposure, species-specific histopathologic lesions, both common background and toxicologically significant lesions, are reviewed. Finally, insight into how regulators synthesize and evaluate these complex findings to assess clinical safety risks is presented.

摘要

开发吸入性药物需要了解肺部解剖学、细胞生物学、呼吸生理学、粒子物理学以及一些管道知识。虽然剂量决定毒性,但在吸入性药物的背景下,“剂量”并不容易定义。剂量方面的这种不明确性给吸入毒理学项目的设计带来了问题和挑战。为了更好地理解剂量,本文讨论了通气的影响以及吸入暴露时观察到的可影响剂量的肺功能扰动。研究了确定吸入药物沉积以估算肺部剂量的方法。对于理解剂量同样重要的是用于向动物递送气雾剂的技术。在更好地理解剂量和吸入暴露的基础上,本文回顾了物种特异性组织病理学病变,包括常见的背景病变和具有毒理学意义的病变。最后,介绍了监管机构如何综合和评估这些复杂的研究结果以评估临床安全风险。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验